BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 31447852)

  • 1. Adoptive T Cell Therapy Following Haploidentical Hematopoietic Stem Cell Transplantation.
    Zhang P; Tey SK
    Front Immunol; 2019; 10():1854. PubMed ID: 31447852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.
    van Balen P; Jedema I; van Loenen MM; de Boer R; van Egmond HM; Hagedoorn RS; Hoogstaten C; Veld SAJ; Hageman L; van Liempt PAG; Zwaginga JJ; Meij P; Veelken H; Falkenburg JHF; Heemskerk MHM
    Front Immunol; 2020; 11():1804. PubMed ID: 32973756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation.
    Baumeister SHC; Rambaldi B; Shapiro RM; Romee R
    Front Immunol; 2020; 11():191. PubMed ID: 32117310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft Engineering and Adoptive Immunotherapy: New Approaches to Promote Immune Tolerance After Hematopoietic Stem Cell Transplantation.
    Bertaina A; Roncarolo MG
    Front Immunol; 2019; 10():1342. PubMed ID: 31354695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation.
    Davies JK; Brennan LL; Wingard JR; Cogle CR; Kapoor N; Shah AJ; Dey BR; Spitzer TR; de Lima M; Cooper LJ; Thall PF; Champlin RE; Nadler LM; Guinan EC
    Clin Cancer Res; 2018 Sep; 24(17):4098-4109. PubMed ID: 29769208
    [No Abstract]   [Full Text] [Related]  

  • 6. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X; Liu D
    Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploidentical hematopoietic cell transplantation.
    Koh LP; Chao N
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S60-S63. PubMed ID: 18724305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation.
    Tey SK; Dotti G; Rooney CM; Heslop HE; Brenner MK
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):913-24. PubMed ID: 17640595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease.
    Chang YJ; Zhao XY; Huang XJ
    Front Immunol; 2018; 9():3041. PubMed ID: 30619371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4
    Mancusi A; Piccinelli S; Velardi A; Pierini A
    Front Immunol; 2019; 10():2901. PubMed ID: 31921162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.
    Di Ianni M; Falzetti F; Carotti A; Terenzi A; Castellino F; Bonifacio E; Del Papa B; Zei T; Ostini RI; Cecchini D; Aloisi T; Perruccio K; Ruggeri L; Balucani C; Pierini A; Sportoletti P; Aristei C; Falini B; Reisner Y; Velardi A; Aversa F; Martelli MF
    Blood; 2011 Apr; 117(14):3921-8. PubMed ID: 21292771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation.
    Di Ianni M; Falzetti F; Carotti A; Terenzi A; Del Papa B; Perruccio K; Ruggeri L; Sportoletti P; Rosati E; Marconi P; Falini B; Reisner Y; Velardi A; Aversa F; Martelli MF
    Best Pract Res Clin Haematol; 2011 Sep; 24(3):459-66. PubMed ID: 21925099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene.
    Zhou X; Di Stasi A; Tey SK; Krance RA; Martinez C; Leung KS; Durett AG; Wu MF; Liu H; Leen AM; Savoldo B; Lin YF; Grilley BJ; Gee AP; Spencer DM; Rooney CM; Heslop HE; Brenner MK; Dotti G
    Blood; 2014 Jun; 123(25):3895-905. PubMed ID: 24753538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
    Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li JM; Hossain MS; Redei I
    Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies.
    Zaghi E; Calvi M; Di Vito C; Mavilio D
    Front Immunol; 2019; 10():2794. PubMed ID: 31849972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation.
    Perruccio K; Topini F; Tosti A; Carotti A; Aloisi T; Aversa F; Martelli MF; Velardi A
    Blood Cells Mol Dis; 2008; 40(1):76-83. PubMed ID: 17977031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in adoptive immunotherapy to accelerate T-cellular immune reconstitution after HLA-incompatible hematopoietic stem cell transplantation.
    Reimann C; Dal Cortivo L; Hacein-Bey-Abina S; Fischer A; André-Schmutz I; Cavazzana-Calvo M
    Immunotherapy; 2010 Jul; 2(4):481-96. PubMed ID: 20636003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmyeloablative allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors: a review.
    Koh LP; Chao NJ
    Blood Cells Mol Dis; 2008; 40(1):20-4. PubMed ID: 17884641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.
    Koh LP; Rizzieri DA; Chao NJ
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1249-67. PubMed ID: 17950913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
    Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.